Getting fenbendazole dosing right is one of the most common questions people have when starting a protocol. This guide covers every dosing consideration — from the original Joe Tippens schedule to higher-dose approaches, cycling patterns, absorption optimization, and safety monitoring.
The Two Standard Doses
Two doses dominate fenbendazole protocols: 222 mg and 444 mg per day. The 222 mg dose traces directly to Joe Tippens' original story — one packet of veterinary Panacur C. The 444 mg dose emerged as practitioners recognized fenbendazole's very low oral bioavailability and concluded that doubling the dose was needed to achieve meaningful tissue concentrations.
For a deeper comparison, see our 222mg vs 444mg guide.
The Cycling Schedule
Fenbendazole is not taken daily without breaks. The standard cycling schedule is:
- 3 days on / 4 days off — the original Joe Tippens schedule
- 5 days on / 2 days off — an alternative used by some practitioners
The cycling serves two purposes: it gives the liver periodic recovery time, and there is a theoretical argument that intermittent dosing may reduce the ability of cancer cells to develop resistance mechanisms against the drug.
How to Take Fenbendazole for Maximum Absorption
Fenbendazole is a Class II compound under the Biopharmaceutics Classification System — meaning it has low water solubility but high permeability once dissolved. The practical takeaway:
- Always take with a fatty meal. Olive oil, avocado, full-fat yogurt, butter, or coconut oil all work. The fat creates micelles that help solubilize fenbendazole in the gut.
- Vitamin E succinate — part of the Joe Tippens protocol — also acts as a fat-soluble carrier and may enhance absorption.
- Do not take on an empty stomach. Absorption drops dramatically without dietary fat.
The Full Joe Tippens Protocol Stack
The Joe Tippens protocol is more than fenbendazole alone. The original daily stack:
| Supplement | Dose | Schedule |
|---|---|---|
| Fenbendazole | 222 mg (or 444 mg) | 3 days on / 4 days off |
| Vitamin E succinate | 400–800 IU | Daily |
| Curcumin (bioavailable) | 600 mg | Daily |
| CBD oil | 25 mg | Daily |
Dosing by Body Weight
In veterinary medicine, fenbendazole is dosed at approximately 50 mg/kg. For a 70 kg (154 lb) human, that would be 3,500 mg — far above any human protocol. The human doses of 222–444 mg represent roughly 3–6 mg/kg, which is well below the veterinary range and contributes to the drug's favorable safety profile at these levels.
There is no established weight-based dosing protocol for humans. The flat 222 mg and 444 mg doses are used regardless of body weight in all major community protocols.
Safety Monitoring
Fenbendazole is generally well-tolerated at these doses. However, responsible use requires monitoring:
- Liver enzymes (ALT, AST) — check every 4–6 weeks. If elevated above 2× the upper limit of normal, pause the protocol and consult your physician.
- Complete blood count (CBC) — fenbendazole can theoretically affect white blood cell counts. Monitor every 2–3 months.
- GI symptoms — mild nausea or loose stools are the most common side effects. Usually resolve within the first 1–2 weeks.
Combining Fenbendazole with Ivermectin
Many protocols now combine fenbendazole with ivermectin. The rationale: they target cancer through completely different mechanisms — fenbendazole disrupts microtubules and glucose uptake, while ivermectin modulates multiple signaling pathways including Wnt/β-catenin and AKT/mTOR.
When combining, both agents are typically cycled on the same schedule (3 on / 4 off). Ivermectin is usually dosed at 0.5–1 mg/kg on dosing days.
Pharmaceutical-Grade vs. Veterinary-Grade
The original Joe Tippens protocol used veterinary Panacur C. However, pharmaceutical-grade fenbendazole offers several advantages:
- Purity: 99%+ verified by Certificate of Analysis
- Consistency: Each capsule delivers a precise, verified dose
- Formulation: Designed for human consumption, without animal-grade binders
- Testing: Third-party lab tested for heavy metals and contaminants
Quick-Reference Dosing Summary
| Protocol | Dose | Schedule | Take with |
|---|---|---|---|
| Joe Tippens (original) | 222 mg | 3 on / 4 off | Fatty meal + Vit E |
| Higher-dose adaptation | 444 mg | 3 on / 4 off | Fatty meal + Vit E |
| Extended cycle | 222–444 mg | 5 on / 2 off | Fatty meal + Vit E |
Frequently Asked Questions
Scientific References
- [1] Dogra N, Kumar A, Mukhopadhyay T (2018). Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death. Scientific Reports. View study →
- [2] Tippens J (2019). My Cancer Story Rocks — original fenbendazole protocol. mycancerstory.rocks. View study →
- [3] Florio R et al. (2020). Fenbendazole affects cell viability through p53-dependent pathways. Cancers (Basel). View study →
- [4] Son DS et al. (2020). The antitumor potentials of benzimidazole anthelmintics as repurposing drugs. Oncotarget. View study →
- [5] Park D et al. (2022). Benzimidazoles as anticancer agents: a review on molecular mechanisms. Journal of Enzyme Inhibition and Medicinal Chemistry. View study →


